Results 51 to 60 of about 64,379 (168)

Co-administration of clomiphene citrate and letrozole in mild ovarian stimulation for POSEIDON Group 4 patients : Supplementary Table 1

open access: yes, 2021
Co-administration of clomiphene citrate and letrozole in mild ovarian stimulation for POSEIDON Group 4 ...
Huang-Tz Ou (8971331)   +4 more
core   +1 more source

Optimizing outcomes in intrauterine insemination: A narrative synthesis of two decades of clinical research (2000–2024)

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 174, Issue 2, Page 718-729, August 2026.
Abstract Intrauterine insemination (IUI) is a widely used first‐line fertility treatment, yet its success rates vary considerably. This review synthesizes evidence from peer‐reviewed studies published between 2000 and 2024, including randomized controlled trials, cohort and case–control studies, as well as systematic and narrative reviews identified ...
Kasuni Akalanka
wiley   +1 more source

Role of Clomiphene Citrate in Anovulation and Hormonal Imbalance of Patients with Polycystic Ovarian Syndrome

open access: yes, 2022
This study was conducted to see the effects of Clomiphene Citrate on fertility hormones estrogen, progesterone, LH, FSH in patients with infertility associated with polycystic ovary syndrome.
Arshad, A. (Asma)   +5 more
core  

Co-administration of clomiphene citrate and letrozole in mild ovarian stimulation for POSEIDON Group 4 patients: Supplementary Table 3

open access: yes, 2021
Co-administration of clomiphene citrate and letrozole in mild ovarian stimulation for POSEIDON Group 4 ...
Huang-Tz Ou (8971331)   +5 more
core   +1 more source

The Oocyte/Antral Follicle Count Index: Does Maximizing Oocyte Yield Translate Into Better Assisted Reproductive Technology Outcomes?

open access: yesJournal of Ultrasound in Medicine, Volume 45, Issue 8, Page 1647-1653, August 2026.
Objectives Whether aspiration of more oocytes than the antral follicle count (AFC) is beneficial for the current and future products of assisted reproductive technologies (ART) cycles. Methods Data of the first oocyte aspiration for intracytoplasmic sperm injection performed between 2018 and 2022 in attempt to conceive (ICSI, n = 399) or for planned ...
Shir Danieli‐Gruber   +7 more
wiley   +1 more source

Histopathological changes in the uterus of rats treated neonatally with clomiphene citrate

open access: yes, 1997
Clomiphene citrate has estrogenic and teratogenic effects on the developing rat and human fetal genital tract. Clomiphene citrate was given subcutaneously to newly born rats by daily injections of 100 ?g/kg and changes caused by clomiphene in female rats
Önen, Abdurrahman   +2 more
core   +1 more source

Oviductus Ranae as a Functional Food for Ovary Protection: Ameliorating Premature Ovarian Failure and Modulating PI3K/Akt and Apoptosis Pathways in Rats

open access: yesFood Science &Nutrition, Volume 14, Issue 7, July 2026.
Schematic illustration of the experimental design for evaluating the protective effects of Oviductus Ranae (OR) against cyclophosphamide (CTX)‐induced premature ovarian failure (POF) in rats. Female Wistar rats were intraperitoneally injected with CTX (100 mg/kg on Day 0, followed by 10 mg/kg daily) for 14–16 days to establish the POF model.
Hongyu Zhao   +6 more
wiley   +1 more source

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. [PDF]

open access: yes, 2009
To assess long-term health effects of ovarian-stimulation drugs we followed-up for over 20 years a British cohort of 7355 women with ovulatory disorders, 43% of whom were prescribed ovarian-stimulation drugs, and identified a total of 274 deaths and 367 ...
Overton, C   +30 more
core   +1 more source

Co-administration of clomiphene citrate and letrozole in mild ovarian stimulation for POSEIDON Group 4 patients : Supplementary Figure 1

open access: yes, 2021
Co-administration of clomiphene citrate and letrozole in mild ovarian stimulation for POSEIDON Group 4 ...
Huang-Tz Ou (8971331)   +4 more
core   +1 more source

Endometriosis: Epidemiology, Risk Factors, Molecular Mechanisms, Diagnosis, and Management

open access: yesMedComm, Volume 7, Issue 7, July 2026.
Global epidemiology, integrated determinants, and disease burden of endometriosis. This circular schematic comprehensively illustrates the global prevalence and demographic variation of endometriosis, its multifactorial integrated determinants, the multifaceted disease burden and economic impact, and recent epidemiological trends, providing a holistic ...
Kun Wang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy